|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
|
|---|---|---|---|
| Net revenues | |||
| Cost of revenues | |||
| Gross profit | |||
| Operating expenses: | |||
| Selling expenses | |||
| General and administrative expenses | |||
| Research and development expenses | |||
| Total operating expenses | |||
| Income/(loss) from operations | |||
| Other (expenses)/income: | |||
| Other non-operating income, net | |||
| Fair value gain (loss) on derivative instruments | |||
| Gain from disposal of subsidiaries | |||
| Government subsidy | |||
| Fair value loss on derivative instruments | |||
| Foreign exchange gain/(loss) | |||
| Interest expense, net | |||
| Interest (expense)/ income, net | |||
| Total other (expenses)/income, net | |||
| Income/(loss) before income tax expense | |||
| Income tax expense | |||
| Net income/(loss) | |||
| Other comprehensive income/(loss) | |||
| Foreign currency translation adjustment | |||
| Total comprehensive income/(loss) | |||
| Net income/(loss) per share | |||
| Basic (in Dollars per share) | |||
| Diluted (in Dollars per share) | |||
| Weighted average shares | |||
| Basic (in Shares) | |||
| Diluted (in Shares) |
Loading...